7 results on '"Habermann, Jens"'
Search Results
2. HDAC2 and TXNL1 distinguish aneuploid from diploid colorectal cancers
- Author
-
Gemoll, Timo, Roblick, Uwe J., Szymczak, Silke, Braunschweig, Till, Becker, Susanne, Igl, Bernd-Wolfgang, Bruch, Hans-Peter, Ziegler, Andreas, Hellman, Ulf, Difilippantonio, Michael J., Ried, Thomas, Jörnvall, Hans, Auer, Gert, and Habermann, Jens K.
- Published
- 2011
- Full Text
- View/download PDF
3. Protein Expression of AEBP1, MCM4, and FABP4 Differentiate Osteogenic, Adipogenic, and Mesenchymal Stromal Stem Cells.
- Author
-
Sauer, Thorben, Facchinetti, Giulia, Kohl, Michael, Kowal, Justyna M., Rozanova, Svitlana, Horn, Julia, Schmal, Hagen, Kwee, Ivo, Schulz, Arndt-Peter, Hartwig, Sonja, Kassem, Moustapha, Habermann, Jens K., and Gemoll, Timo
- Subjects
MESENCHYMAL stem cells ,PROTEIN expression ,TANDEM mass spectrometry ,PEROXISOME proliferator-activated receptors ,MASS spectrometry - Abstract
Mesenchymal stem cells (MSCs) gain an increasing focus in the field of regenerative medicine due to their differentiation abilities into chondrocytes, adipocytes, and osteoblastic cells. However, it is apparent that the transformation processes are extremely complex and cause cellular heterogeneity. The study aimed to characterize differences between MSCs and cells after adipogenic (AD) or osteoblastic (OB) differentiation at the proteome level. Comparative proteomic profiling was performed using tandem mass spectrometry in data-independent acquisition mode. Proteins were quantified by deep neural networks in library-free mode and correlated to the Molecular Signature Database (MSigDB) hallmark gene set collections for functional annotation. We analyzed 4108 proteins across all samples, which revealed a distinct clustering between MSCs and cell differentiation states. Protein expression profiling identified activation of the Peroxisome proliferator-activated receptors (PPARs) signaling pathway after AD. In addition, two distinct protein marker panels could be defined for osteoblastic and adipocytic cell lineages. Hereby, overexpression of AEBP1 and MCM4 for OB as well as of FABP4 for AD was detected as the most promising molecular markers. Combination of deep neural network and machine-learning algorithms with data-independent mass spectrometry distinguish MSCs and cell lineages after adipogenic or osteoblastic differentiation. We identified specific proteins as the molecular basis for bone formation, which could be used for regenerative medicine in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Chromosomal aneuploidy affects the global proteome equilibrium of colorectal cancer cells.
- Author
-
Gemoll, Timo, Habermann, Jens K., Becker, Susanne, Szymczak, Silke, Upender, Madhvi B., Bruch, Hans-Peter, Hellman, Ulf, Ried, Thomas, Auer, Gert, Jörnvall, Hans, and Roblick, Uwe J.
- Subjects
- *
ANEUPLOIDY , *PROTEOMICS , *COLON cancer , *CANCER cells , *PROTEIN expression - Abstract
BACKGROUND: Chromosomal aneuploidy has been identified as a prognostic factor in the majority of sporadic carcinomas. However, it is not known how chromosomal aneuploidy affects chromosome-specific protein expression in particular, and the cellular proteome equilibrium in general. OBJECTIVE: The aim was to detect chromosomal aneuploidy-associated expression changes in cell clones carrying trisomies found in colorectal cancer. METHODS: We used microcell-mediated chromosomal transfer to generate three artificial trisomic cell clones of the karyotypically stable, diploid, yet mismatch-deficient, colorectal cancer cell line DLD1 - each of them harboring one extra copy of either chromosome 3, 7 or 13. Protein expression differences were assessed by two-dimensional gel electrophoresis and mass spectrometry, compared to whole-genome gene expression data, and evaluated by PANTHER classification system and Ingenuity Pathway Analysis (IPA). RESULTS: In total, 79 differentially expressed proteins were identified between the trisomic clones and the parental cell line. Up-regulation of PCNA and HMGB1 as well as down-regulation of IDH3A and PSMB3 were revealed as trisomy-associated alterations involved in regulating genome stability. CONCLUSIONS: These results show that trisomies affect the expression of genes and proteins that are not necessarily located on the trisomic chromosome, but reflect a pathway-related alteration of the cellular equilibrium. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
5. The impact of pre-analytical conditions on the serum proteome: heat-stabilization versus nitrogen storage.
- Author
-
Gemoll, Timo, Löwe, Oliver, Borén, Mats, Oberländer, Martina, Hartwig, Sonja, Lehr, Stefan, Roblick, Uwe J., Auer, Gert, Jörnvall, Hans, and Habermann, Jens K.
- Subjects
HEAT stability in proteins ,BLOOD proteins ,PROTEOMICS ,BIOMATERIALS ,PHYSIOLOGICAL effects of nitrogen ,BIOMARKERS ,GEL electrophoresis ,GENE expression - Abstract
Context: Biological material reflecting the in vivo composition of markers provides a high potential for biomarker discovery. Objective: We compared the serum proteome following heat- and nitrogen-preservation, with and without subsequent storage at room temperature. Materials and methods: Serum samples were collected, treated and analysed by two-dimensional gel electrophoresis. Protein spots were identified and confirmed by two mass spectrometry approaches (MALDI & ESI) and subjected to Ingenuity Pathway Analysis. Results: We revealed 24 differentially expressed proteins ( p ≤ 0.05) between nitrogen and heat preservation, and 87 between nitrogen and heat preservation with subsequent storage for 120 h at room-temperature. Mass spectrometry identified 25 polypeptides. Pathway analysis resulted in networks maintaining Cellular Assembly and Organization, Movement and Maintenance. Conclusion: Heat-stabilization does not substantially change the short-term proteome composition of serum compared with nitrogen treatment. However, heat-stabilization alone seems insufficient for long-term sample preservation for serum samples. We identified transthyretin and apolipoprotein A-IV as sample quality markers. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
6. SELDI-TOF serum proteomics and colorectal cancer: A current overview.
- Author
-
Gemoll, Timo, Roblick, Uwe Johannes, Auer, Gert, Jörnvall, Hans, and Habermann, Jens Karsten
- Subjects
PROTEOMICS ,COLON cancer diagnosis ,MASS spectrometry ,BIOMARKERS ,LITERATURE reviews ,SERODIAGNOSIS ,BLOOD plasma - Abstract
Surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) is a widely used technology platform for diagnostic biomarker discovery in tissue, plasma and serum. High-throughput and simplicity of experimental procedures have allowed this technology to become an important research tool for biomarker discovery during the last years. This review provides an overview of SELDI-TOF functionality, its advantages and drawbacks and gives a current literature overview of colorectal cancer based serum biomarker detection. Further improvements in instrumentation sensitivity and labelling chemistries will enable detection of novel, tissue-leakage biomarkers in serum. However, major emphasis should be given on subsequent identification of differentially observed protein peaks detected by SELDI-TOF. Clinical validation in large patient cohorts will then allow transferring novel biomarkers into clinical use. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
7. Spatial UBE2N protein expression indicates genomic instability in colorectal cancers.
- Author
-
Gemoll, Timo, Miroll, Elena, Klein, Oliver, Lischka, Annette, Eravci, Murat, Thorns, Christoph, and Habermann, Jens K.
- Subjects
PROTEIN expression ,COLORECTAL cancer ,MASS spectrometry ,TISSUE extracts ,TISSUE analysis - Abstract
Background: One major hallmark of colorectal cancers (CRC) is genomic instability with its contribution to tumor heterogeneity and therapy resistance. To facilitate the investigation of intra-sample phenotypes and the de novo identification of tumor sub-populations, imaging mass spectrometry (IMS) provides a powerful technique to elucidate the spatial distribution patterns of peptides and proteins in tissue sections.Methods: In the present study, we analyzed an in-house compiled tissue microarray (n = 60) comprising CRCs and control tissues by IMS. After obtaining protein profiles through direct analysis of tissue sections, two validation sets were used for immunohistochemical evaluation.Results: A total of 28 m/z values in the mass range 800-3500 Da distinguished euploid from aneuploid CRCs (p < 0.001, ROC AUC values < 0.385 or > 0.635). After liquid chromatograph-mass spectrometry identification, UBE2N could be successfully validated by immunohistochemistry in the initial sample cohort (p = 0.0274, ROC AUC = 0.7937) and in an independent sample set of 90 clinical specimens (p = 0.0070, ROC AUC = 0.6957).Conclusions: The results showed that FFPE protein expression profiling of surgically resected CRC tissue extracts by MALDI-TOF MS has potential value for improved molecular classification. Particularly, the protein expression of UBE2N was validated in an independent clinical cohort to distinguish euploid from aneuploid CRCs. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.